This inventor holds 3 USPTO granted patents. Top assignees: Bio Research Corporation of Yokohama, Ensuiko Sugar Refining Co., Ltd., Kaken Pharmaceutical Company, Ltd.. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2000-2002
Title: Innovations of Katsuyoshi Nakanishi
Introduction
Katsuyoshi Nakanishi is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of baccatin derivatives and taxoid compounds. With a total of 3 patents to his name, Nakanishi's work has implications for the pharmaceutical industry.
Latest Patents
Nakanishi's latest patents include innovative processes for producing baccatin derivatives. One of his key inventions focuses on developing baccatin derivatives useful for preparing taxoid compounds such as paclitaxel. This process involves allowing a baccatin to react with a β-ketoester, either in the absence of a catalyst or in the presence of a tin compound or an amine base, preferably under reduced pressure. Another significant patent details a method for producing taxoid compounds from baccatin derivatives, specifically through transesterification, which allows for the creation of taxoid compounds under mild conditions.
Career Highlights
Throughout his career, Nakanishi has worked with various companies, including Bio Research Corporation of Yokohama and Ensuiko Sugar Refining Co., Ltd. His experience in these organizations has contributed to his expertise in the field of chemical innovations.
Collaborations
Nakanishi has collaborated with notable colleagues such as Tadakatsu Mandai and Hiroshi Okumoto. These partnerships have likely enhanced his research and development efforts in the field of chemistry.
Conclusion
Katsuyoshi Nakanishi's contributions to the field of chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of important pharmaceutical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile